{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T21:16:04Z","timestamp":1788988564231,"version":"build-2803163510"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"CHUQ Research Center"},{"DOI":"10.13039\/100007867","name":"Laval University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007867","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institute of Health Research","doi-asserted-by":"crossref","award":["275325"],"award-info":[{"award-number":["275325"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Canadian Foundation for Innovation","award":["25631"],"award-info":[{"award-number":["25631"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.nbd.2015.05.017","type":"journal-article","created":{"date-parts":[[2015,6,6]],"date-time":"2015-06-06T00:03:25Z","timestamp":1433549005000},"page":"99-113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"special_numbering":"C","title":["GPER1-mediated immunomodulation and neuroprotection in the myenteric plexus of a mouse model of Parkinson's disease"],"prefix":"10.1016","volume":"82","author":[{"given":"M\u00e9lissa","family":"C\u00f4t\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9lanie","family":"Bourque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9e-Anne","family":"Poirier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Aub\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Morissette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Th\u00e9r\u00e8se","family":"Di Paolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Soulet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.nbd.2015.05.017_bb0005","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1212\/WNL.57.3.456","article-title":"Frequency of bowel movements and the future risk of Parkinson's disease","volume":"57","author":"Abbott","year":"2001","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.nbd.2015.05.017_bb0010","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.expneurol.2007.05.010","article-title":"Loss of enteric dopaminergic neurons and associated changes in colon motility in an MPTP mouse model of Parkinson's disease","volume":"207","author":"Anderson","year":"2007","journal-title":"Exp. Neurol."},{"issue":"5","key":"10.1016\/j.nbd.2015.05.017_bb0015","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00401-012-1040-2","article-title":"Parkinson's disease is not associated with gastrointestinal myenteric ganglion neuron loss","volume":"124","author":"Annerino","year":"2012","journal-title":"Acta Neuropathol."},{"issue":"1","key":"10.1016\/j.nbd.2015.05.017_bb0020","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.neuroscience.2007.09.084","article-title":"Impaired nerve regeneration and enhanced neuroinflammatory response in mice lacking pituitary adenylyl cyclase activating peptide","volume":"151","author":"Armstrong","year":"2008","journal-title":"Neuroscience"},{"issue":"4","key":"10.1016\/j.nbd.2015.05.017_bb0025","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/nchembio775","article-title":"Virtual and biomolecular screening converge on a selective agonist for GPR30","volume":"2","author":"Bologa","year":"2006","journal-title":"Nat. Chem. Biol."},{"issue":"2","key":"10.1016\/j.nbd.2015.05.017_bb0030","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.yfrne.2009.04.014","article-title":"Neuroprotective actions of sex steroids in Parkinson's disease","volume":"30","author":"Bourque","year":"2009","journal-title":"Front. Neuroendocrinol."},{"issue":"3","key":"10.1016\/j.nbd.2015.05.017_bb0035","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.neurobiolaging.2012.05.022","article-title":"Implication of GPER1 in neuroprotection in a mouse model of Parkinson's disease","volume":"34","author":"Bourque","year":"2013","journal-title":"Neurobiol. Aging"},{"issue":"2","key":"10.1016\/j.nbd.2015.05.017_bb0040","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"issue":"4","key":"10.1016\/j.nbd.2015.05.017_bb0045","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/1098-2396(20000915)37:4<245::AID-SYN1>3.0.CO;2-5","article-title":"Stereospecific prevention by 17beta-estradiol of MPTP-induced dopamine depletion in mice","volume":"37","author":"Callier","year":"2000","journal-title":"Synapse"},{"issue":"6","key":"10.1016\/j.nbd.2015.05.017_bb0050","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.bbi.2011.02.017","article-title":"The critical role of the MyD88-dependent pathway in non-CNS MPTP-mediated toxicity","volume":"25","author":"Cote","year":"2011","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.nbd.2015.05.017_bb0055","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.bbi.2015.01.009","article-title":"Partial depletion of the proinflammatory monocyte population is neuroprotective in the myenteric plexus but not in the basal ganglia in a MPTP mouse model of Parkinson's disease","volume":"46","author":"Cote","year":"2015","journal-title":"Brain Behav. Immun."},{"issue":"13","key":"10.1016\/j.nbd.2015.05.017_bb0060","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1096\/fj.02-1029fje","article-title":"Vasoactive intestinal peptide prevents activated microglia-induced neurodegeneration under inflammatory conditions: potential therapeutic role in brain trauma","volume":"17","author":"Delgado","year":"2003","journal-title":"FASEB J."},{"issue":"6","key":"10.1016\/j.nbd.2015.05.017_bb0065","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nchembio.168","article-title":"In vivo effects of a GPR30 antagonist","volume":"5","author":"Dennis","year":"2009","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.nbd.2015.05.017_bb0070","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.nbd.2012.09.007","article-title":"Colonic inflammation in Parkinson's disease","volume":"50","author":"Devos","year":"2013","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.nbd.2015.05.017_bb0075","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.nbd.2009.06.017","article-title":"Chronic rotenone exposure reproduces Parkinson's disease gastrointestinal neuropathology","volume":"36","author":"Drolet","year":"2009","journal-title":"Neurobiol. Dis."},{"issue":"12","key":"10.1016\/j.nbd.2015.05.017_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028032","article-title":"Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson's disease","volume":"6","author":"Forsyth","year":"2011","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.nbd.2015.05.017_bb0085","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.expneurol.2009.04.023","article-title":"Delayed gastric emptying and enteric nervous system dysfunction in the rotenone model of Parkinson's disease","volume":"218","author":"Greene","year":"2009","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2015.05.017_bb0090","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1749-6632.2009.04365.x","article-title":"Parkinson's disease: the dual hit theory revisited","volume":"1170","author":"Hawkes","year":"2009","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"4","key":"10.1016\/j.nbd.2015.05.017_bb0095","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S1474-4422(09)70062-6","article-title":"Neuroinflammation in Parkinson's disease: a target for neuroprotection?","volume":"8","author":"Hirsch","year":"2009","journal-title":"Lancet Neurol."},{"issue":"1\u20132","key":"10.1016\/j.nbd.2015.05.017_bb0100","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0165-0270(95)00064-X","article-title":"Cuprolinic blue (quinolinic phthalocyanine) counterstaining of enteric neurons for peroxidase immunocytochemistry","volume":"62","author":"Holst","year":"1995","journal-title":"J. Neurosci. Methods"},{"issue":"8","key":"10.1016\/j.nbd.2015.05.017_bb0105","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/mds.25736","article-title":"Progression of intestinal permeability changes and alpha-synuclein expression in a mouse model of Parkinson's disease","volume":"29","author":"Kelly","year":"2014","journal-title":"Mov. Disord."},{"issue":"9","key":"10.1016\/j.nbd.2015.05.017_bb0110","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1093\/hmg\/ddq038","article-title":"Extensive enteric nervous system abnormalities in mice transgenic for artificial chromosomes containing Parkinson disease-associated alpha-synuclein gene mutations precede central nervous system changes","volume":"19","author":"Kuo","year":"2010","journal-title":"Hum. Mol. Genet."},{"issue":"12","key":"10.1016\/j.nbd.2015.05.017_bb0115","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1136\/gut.2008.162503","article-title":"Pathological lesions in colonic biopsies during Parkinson's disease","volume":"57","author":"Lebouvier","year":"2008","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.nbd.2015.05.017_bb0120","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/j.1460-9568.2009.06873.x","article-title":"The second brain and Parkinson's disease","volume":"30","author":"Lebouvier","year":"2009","journal-title":"Eur. J. Neurosci."},{"issue":"1","key":"10.1016\/j.nbd.2015.05.017_bb0125","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1111\/j.1365-2982.2009.01368.x","article-title":"Routine colonic biopsies as a new tool to study the enteric nervous system in living patients","volume":"22","author":"Lebouvier","year":"2010","journal-title":"Neurogastroenterol. Motil."},{"issue":"9","key":"10.1016\/j.nbd.2015.05.017_bb0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012728","article-title":"Colonic biopsies to assess the neuropathology of Parkinson's disease and its relationship with symptoms","volume":"5","author":"Lebouvier","year":"2010","journal-title":"PLoS ONE"},{"issue":"10","key":"10.1016\/j.nbd.2015.05.017_bb0135","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1523\/JNEUROSCI.4720-05.2006","article-title":"Physiological modulation of intestinal motility by enteric dopaminergic neurons and the D2 receptor: analysis of dopamine receptor expression, location, development, and function in wild-type and knock-out mice","volume":"26","author":"Li","year":"2006","journal-title":"J. Neurosci."},{"issue":"7","key":"10.1016\/j.nbd.2015.05.017_bb0140","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1440-1681.2007.04616.x","article-title":"Oestrogen and nigrostriatal dopaminergic neurodegeneration: animal models and clinical reports of Parkinson's disease","volume":"34","author":"Liu","year":"2007","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"Suppl. 1","key":"10.1016\/j.nbd.2015.05.017_bb0145","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.parkreldis.2004.01.005","article-title":"Inflammation and neurodegeneration in Parkinson's disease","volume":"10","author":"McGeer","year":"2004","journal-title":"Parkinsonism Relat. Disord."},{"issue":"1","key":"10.1016\/j.nbd.2015.05.017_bb0150","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0304-3940(96)12706-3","article-title":"Interleukin (IL)-1 beta, IL-2, IL-4, IL-6 and transforming growth factor-alpha levels are elevated in ventricular cerebrospinal fluid in juvenile parkinsonism and Parkinson's disease","volume":"211","author":"Mogi","year":"1996","journal-title":"Neurosci. Lett."},{"issue":"3","key":"10.1016\/j.nbd.2015.05.017_bb0155","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.neuroscience.2005.07.060","article-title":"Estrogen, neuroinflammation and neuroprotection in Parkinson's disease: glia dictates resistance versus vulnerability to neurodegeneration","volume":"138","author":"Morale","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2015.05.017_bb0160","first-page":"143","article-title":"Cytokines in Parkinson's disease","volume":"58","author":"Nagatsu","year":"2000","journal-title":"J. Neural Transm. Suppl."},{"key":"10.1016\/j.nbd.2015.05.017_bb0165","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.brainres.2010.07.076","article-title":"MPTP-induced parkinsonism extends to a subclass of TH-positive neurons in the gut","volume":"1355","author":"Natale","year":"2010","journal-title":"Brain Res."},{"issue":"7","key":"10.1016\/j.nbd.2015.05.017_bb0170","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/j.1365-2982.2008.01162.x","article-title":"Parkinson's disease and the gut: a well known clinical association in need of an effective cure and explanation","volume":"20","author":"Natale","year":"2008","journal-title":"Neurogastroenterol. Motil."},{"issue":"1","key":"10.1016\/j.nbd.2015.05.017_bb0175","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.nbd.2012.06.005","article-title":"Alpha-synuclein transgenic mice display age-related slowing of gastrointestinal motility associated with transgene expression in the vagal system","volume":"48","author":"Noorian","year":"2012","journal-title":"Neurobiol. Dis."},{"issue":"19","key":"10.1016\/j.nbd.2015.05.017_bb0180","doi-asserted-by":"crossref","first-page":"7488","DOI":"10.1073\/pnas.0600375103","article-title":"Pituitary adenylate cyclase-activating polypeptide (PACAP) decreases ischemic neuronal cell death in association with IL-6","volume":"103","author":"Ohtaki","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1\u20132","key":"10.1016\/j.nbd.2015.05.017_bb0185","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jsbmb.2008.05.003","article-title":"In vivo characterization of estrogen receptor modulators with reduced genomic versus nongenomic activity in vitro","volume":"111","author":"Otto","year":"2008","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"2","key":"10.1016\/j.nbd.2015.05.017_bb0190","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S1474-4422(03)00307-7","article-title":"Gastrointestinal dysfunction in Parkinson's disease","volume":"2","author":"Pfeiffer","year":"2003","journal-title":"Lancet Neurol."},{"issue":"3","key":"10.1016\/j.nbd.2015.05.017_bb0195","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.neuroscience.2008.02.074","article-title":"Alpha-synuclein-immunopositive myenteric neurons and vagal preganglionic terminals: autonomic pathway implicated in Parkinson's disease?","volume":"153","author":"Phillips","year":"2008","journal-title":"Neuroscience"},{"issue":"Suppl. 7","key":"10.1016\/j.nbd.2015.05.017_bb0200","first-page":"VII2","article-title":"The natural history of Parkinson's disease","volume":"253","author":"Poewe","year":"2006","journal-title":"J. Neurol."},{"issue":"5","key":"10.1016\/j.nbd.2015.05.017_bb0205","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1159\/000314478","article-title":"Clinical criteria for the diagnosis of Parkinson's disease","volume":"7","author":"Reichmann","year":"2010","journal-title":"Neurodegener. Dis."},{"issue":"21","key":"10.1016\/j.nbd.2015.05.017_bb0210","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1212\/WNL.0b013e3181c34af5","article-title":"Medical records documentation of constipation preceding Parkinson disease: a case\u2013control study","volume":"73","author":"Savica","year":"2009","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.nbd.2015.05.017_bb0215","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1001\/archneurol.2010.135","article-title":"When does Parkinson disease start?","volume":"67","author":"Savica","year":"2010","journal-title":"Arch. Neurol."},{"issue":"3","key":"10.1016\/j.nbd.2015.05.017_bb0220","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/ana.20789","article-title":"Timing of treatment initiation in Parkinson's disease: a need for reappraisal?","volume":"59","author":"Schapira","year":"2006","journal-title":"Ann. Neurol."},{"issue":"6","key":"10.1016\/j.nbd.2015.05.017_bb0225","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/mds.23838","article-title":"Alpha-synuclein in colonic submucosa in early untreated Parkinson's disease","volume":"27","author":"Shannon","year":"2012","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.nbd.2015.05.017_bb0230","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ab.2006.12.036","article-title":"Minimization of PCR efficiency differences between standards and samples through dilution of PCR amplicons in reverse transcription buffer","volume":"362","author":"Simard","year":"2007","journal-title":"Anal. Biochem."},{"issue":"8979","key":"10.1016\/j.nbd.2015.05.017_bb0235","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0140-6736(95)92707-7","article-title":"Dopaminergic defect of enteric nervous system in Parkinson's disease patients with chronic constipation","volume":"346","author":"Singaram","year":"1995","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.nbd.2015.05.017_bb0240","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1210\/er.2007-0001","article-title":"The complex role of estrogens in inflammation","volume":"28","author":"Straub","year":"2007","journal-title":"Endocr. Rev."},{"issue":"6","key":"10.1016\/j.nbd.2015.05.017_bb0245","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1073\/pnas.0812257106","article-title":"Pituitary adenylyl cyclase-activating polypeptide is an intrinsic regulator of Treg abundance and protects against experimental autoimmune encephalomyelitis","volume":"106","author":"Tan","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.nbd.2015.05.017_bb0250","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1210\/jc.2010-0536","article-title":"Update in hormone therapy use in menopause","volume":"96","author":"Taylor","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.nbd.2015.05.017_bb0255","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.brainres.2006.02.029","article-title":"Estrogen down-regulates glial activation in male mice following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine intoxication","volume":"1084","author":"Tripanichkul","year":"2006","journal-title":"Brain Res."},{"issue":"7","key":"10.1016\/j.nbd.2015.05.017_bb0260","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2002-3-7-research0034","article-title":"Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes","volume":"3","author":"Vandesompele","year":"2002","journal-title":"Genome Biol."},{"issue":"6","key":"10.1016\/j.nbd.2015.05.017_bb0265","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/BF00294234","article-title":"Parkinson's disease: an immunohistochemical study of Lewy body-containing neurons in the enteric nervous system","volume":"79","author":"Wakabayashi","year":"1990","journal-title":"Acta Neuropathol."},{"issue":"8","key":"10.1016\/j.nbd.2015.05.017_bb0270","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1097\/WNR.0b013e3282ffda5e","article-title":"Abnormal colonic motility in mice overexpressing human wild-type alpha-synuclein","volume":"19","author":"Wang","year":"2008","journal-title":"Neuroreport"},{"issue":"9","key":"10.1016\/j.nbd.2015.05.017_bb0275","doi-asserted-by":"crossref","first-page":"e425","DOI":"10.1111\/j.1365-2982.2012.01974.x","article-title":"Mice overexpressing wild-type human alpha-synuclein display alterations in colonic myenteric ganglia and defecation","volume":"24","author":"Wang","year":"2012","journal-title":"Neurogastroenterol. Motil."},{"issue":"3","key":"10.1016\/j.nbd.2015.05.017_bb0280","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1189\/jlb.0806510","article-title":"The CD14+ CD16+ blood monocytes: their role in infection and inflammation","volume":"81","author":"Ziegler-Heitbrock","year":"2007","journal-title":"J. Leukoc. Biol."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996115001916?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996115001916?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,9]],"date-time":"2024-06-09T11:06:07Z","timestamp":1717931167000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996115001916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":56,"alternative-id":["S0969996115001916"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2015.05.017","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GPER1-mediated immunomodulation and neuroprotection in the myenteric plexus of a mouse model of Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2015.05.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}